Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Jose Alonso

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|November 19, 2016
Polyarginine Nanocapsules as a Potential Oral Peptide Delivery CarrierGiovanna Lollo, Ana Gonzalez-Paredes, Marcos Garcia-Fuentes, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transferNoemi Csaba, Magnus Köping-Höggård, Eduardo Fernandez-Megia, et al.
International Journal of Pharmaceutics|May 17, 2005
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitorYeşim Aktaş, Karine Andrieux, Maria Jose Alonso, et al.
ACS Nano|April 10, 2019
Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide AntigenTamara G Dacoba, Robert W Omange, Hongzhao Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 21, 2016
Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsulesRaquel Abellan-Pose, Maria Rodríguez-Évora, Sara Vicente, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2010
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factorsYolanda Parajó, Ivana d'Angelo, Aniko Horváth, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approachLungile Nomcebo Thwala, Ana Beloqui, Noemi Stefania Csaba, et al.
International Journal of Pharmaceutics|March 5, 2013
Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticlesAdriana Trapani, Sante Di Gioia, Nicoletta Ditaranto, et al.
Journal of Nanobiotechnology|June 25, 2016
Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph nodeMarta Alonso-Nocelo, Raquel Abellan-Pose, Anxo Vidal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2018
Protamine nanocapsules as carriers for oral peptide deliveryLungile Nomcebo Thwala, Diego Pan Delgado, Kevin Leone, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|November 19, 2016
Polyarginine Nanocapsules as a Potential Oral Peptide Delivery CarrierGiovanna Lollo, Ana Gonzalez-Paredes, Marcos Garcia-Fuentes, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transferNoemi Csaba, Magnus Köping-Höggård, Eduardo Fernandez-Megia, et al.
International Journal of Pharmaceutics|May 17, 2005
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitorYeşim Aktaş, Karine Andrieux, Maria Jose Alonso, et al.
ACS Nano|April 10, 2019
Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide AntigenTamara G Dacoba, Robert W Omange, Hongzhao Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 21, 2016
Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsulesRaquel Abellan-Pose, Maria Rodríguez-Évora, Sara Vicente, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2010
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factorsYolanda Parajó, Ivana d'Angelo, Aniko Horváth, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approachLungile Nomcebo Thwala, Ana Beloqui, Noemi Stefania Csaba, et al.
International Journal of Pharmaceutics|March 5, 2013
Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticlesAdriana Trapani, Sante Di Gioia, Nicoletta Ditaranto, et al.
Journal of Nanobiotechnology|June 25, 2016
Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph nodeMarta Alonso-Nocelo, Raquel Abellan-Pose, Anxo Vidal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2018
Protamine nanocapsules as carriers for oral peptide deliveryLungile Nomcebo Thwala, Diego Pan Delgado, Kevin Leone, et al.
Pageof 3